David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Bionano Genomics Stock Can Regain the Crucial $5 Level

Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.

Don’t Underestimate the Upside Potential of Digital World Acquisition

DWAC stock is controversial and not appropriate for everyone, but betting against it could be a portfolio-wrecking misjudgment.

Capture Profits in New Digital Worlds With Matterport Stock

MTTR stock has fallen below its IPO price, but that's not a sell signal as Matterport demonstrates powerful platform subscriber growth.

Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022

CLOV stock is high-risk but potentially also high-reward as Clover Health rakes in the revenue and helps at-risk patients get healthcare.

What’s So Special About Clover Health?

As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology.